PRIMARY BILIARY CHOLANGITIS (PBC)
Clinical trials for PRIMARY BILIARY CHOLANGITIS (PBC) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS (PBC) trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS (PBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to help Hard-to-Treat PBC patients
Disease control ENROLLING_BY_INVITATIONThis study looks at whether adding the steroid prednisone to the usual medicine (ursodeoxycholic acid) can improve outcomes for people with primary biliary cholangitis (PBC) who also have moderate to severe liver inflammation. About 244 adults with PBC will take either the combin…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: PHASE2, PHASE3 • Sponsor: Han Ying • Aim: Disease control
Last updated May 26, 2026 05:55 UTC
-
New hope for PBC patients: experimental drug CS0159 enters Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called CS0159 in 75 adults with primary biliary cholangitis (PBC), a chronic liver disease. The goal is to see if the drug is safe and can improve liver health markers like ALP levels. Participants receive either CS0159 or a placebo for 12 we…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated May 26, 2026 05:55 UTC